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446a Tuesday, March 3, 2009several disease-causing mutations in ClC-5 translate into truncations of the
carboxy terminus (Ct), highlighting the significance of this region. The Ct in-
teracts with the scaffold protein NHERF2 (Naþ/Hþ exchanger regulatory fac-
tor 2) and leads to enhanced endocytic uptake of albumin by kidney cells
[Hryciw, D. et al. 2006]. This interaction occurs through the second PDZ do-
main of NHERF2 and an unknown binding site on the Ct of ClC-5 [Hryciw,
D. et al. 2006]. In the present study NHERF2/ClC-5 Ct interactions were con-
firmed and a putative internal PDZ binding motif TSII (residues 657-60) was
identified in the Ct. Mapping of this motif on the crystal structure of ClC-5
reveals it lies up-stream of a b-turn, a secondary structure element thought
to be critical for PDZ domain recognition of an internal motif [Hillier, B.
et al. 1999]. The strategic S658A mutation completely abolishes NHERF2
binding in vitro suggesting the PDZ binding motif was targeted. CD analysis
confirmed similar spectra between wildtype and S658A mutant, indicating
that this mutation does not lead to gross misfolding of the Ct. The disease mu-
tant R648X which removes this critical S658 abolishes NHERF2 interactions
providing further evidence the internal PDZ binding motif was targeted. Fu-
ture work will focus on identifying proteins interacting with the ClC-5/
NHERF2 complex and deciphering the role of this complex in renal endocy-
tosis. This work was supported by the Kidney Foundation of Canada operating
gant to C.B. and a NSERC studentship to L.W.
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Fibroblast Growth Factors (FGFs) belong to a large family of b-trefoil poly-
peptide growth factors and contain no disulfide binds. FGFs are involved in
various important biological processes such as development and maintenance
of cells. FGFs are about 154 amino acids long and are believed to share
a common core of 140 amino acids with 6 invariant proline residues. The
secondary structural elements in FGFs include 12 antiparallel beta-sheets ar-
ranged in to a beta-barrel motif. Critical analyses of the three-dimensional
structure of human acidic fibroblast factpr (hFGF-1) show that proline resi-
dues play a critical role in shaping the beta-barrel architecture of the protein.
In this context, using a site-directed mutagenesis approach, we examined the
effects of substitution of proline on the structure, stability and function of
hFGF-1. The stability of of the various proline mutants of FGF-1, were as-
sessed by differential scanning calorimetry, limited proteolytic digestion,
and urea-induced equilibrium unfolding. Conformational changes induced
in the various proline mutants of hFGF-1 have been studied using 1-ani-
lino-8-napthalene sulfonate binding, far UV circular dichroism, and multidi-
mensional NMR spectroscopy. The heparin and receptor binding affinities of
the hFGF-1 mutants were investigated by isothermal titration calorimetry.
The results of this study are expected to provide valuable information for a ra-
tional design of hFGF-1 with increased stability and enhanced cell prolifer-
ation activity.
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HIV-1 reverse transcriptase is a complex multi-subunit enzyme that converts
single stranded viral RNA into double stranded proviral DNA. This enzyme
possesses both DNA polymerase and RNase H activity. Structurally, RT is
composed of a 66 kD (p66) subunit and a 51 kD (p51) subunit that lacks an RN-
ase H domain. The homodimers retain DNA polymerase activity but only the
p66/p66 homodimer has RNase H activity. In solution, the enzyme exists as
an equilibrium mixture of the heterodimer p66/p51, two homodimers p66/
p66 and p51/p51 and the two monomers. The nonnucleoside reversible inhib-
itor (NNRTI) efavirenz enhances dimerization of p66/p51, p66/p66, and p51/
p51. The drug binds both monomeric and dimeric RTs. However, structural
changes induced by drug binding are unknown. A combination of hydrogen
deuterium exchange and mass spectrometry is used to probe the solution struc-
ture of RT monomers in the presence and absence of efavirenz. Here we dem-
onstrate that p66 and p51 monomers have similar solution structures, which
resemble the p51 subunit in the crystal structure of p66/p51 heterodimer. After
drug binding the solution structure of the monomers changes to resemble the
p66 subunit in the crystal structure of the heterodimer. We also show that res-
idues in the drug binding pocket of p66/p51-efavirenz complex are affected by
drug binding to monomer.2302-Pos Board B272
Stabilizing Interactions In TNF Ligand-receptor Binding
Christopher Valley, Jonathan Sachs.
University of Minnesota, Minneapolis, MN, USA.
High-affinity binding of extracellular protein ligands belonging to the tumor
necrosis factor (TNF) superfamily to their conjugate transmembrane cell sur-
face TNF receptors initiates the extrinsic signaling cascade that results in apo-
ptotic cell death. Intriguingly, despite a high-degree of structural homology
among the family of ligands and receptors, the ligand binding is both high-af-
finity and has high-specificity. As yet, it is poorly understood what confers this
specificity. Starting from the crystal structures for the TRAIL-death receptor 5
and LTa-TNF receptor 1 complexes, we used all-atom molecular dynamics
simulations to investigate the stabilizing interactions between these ligand-re-
ceptor pairs. Additionally, we simulated both complexes with destabilizing
point mutations. The simulation results yield insight into published experimen-
tal data as well as the underlying mechanism of high affinity ligand-receptor
binding.
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Fibroblast growth factors (FGFs) are heparin binding proteins that help regulate
key cellular processes such as wound healing and differentiation, cell prolifer-
ation, cell migration, morphogenesis, and angiogenesis. The FGF signaling is
generated by the binding of the ligand (FGF) to the extracellular domain of
the FGFR, this binding induces dimerization of FGFR, which is an essential
step in FGF signaling. Fibroblast growth factor receptor (FGFR) extracellular
domain consists of three Ig domains D1, D2, and D3. Between the Domains
D1 and D2 is a short span of acidic residues called the ‘‘acid box’’. The D1-
D2 linker is thought to play a role in regulation of FGF interaction with
FGFR. Many of the FGF binding sites can be found on the extracellular D2 do-
main of the receptor. It is believed that ‘‘acid box’’ can regulate FGF binding to
FGFR. The ‘‘acid box’’ can mimic heparin like compounds and bind at the hep-
arin binding sites located on the surface of the D2 region of FGFR. In the pres-
ent study, we synthesized a twenty-eight amino acid box region peptide and
studied its interaction with D2 domain of FGFR using various biophysical tech-
niques including multidimensional NMR spectroscopy. Equilibrium unfolding
experiment monitored steady state fluorescence, far-UV circular dichrosim and
proteolytic digestion experiments reveal that acid box binds to D2 domain very
weakly. Two-dimensional nuclear magnetic resonance 1H-15N HSQC experi-
ments show that the acid box binds to the FGF-1 and heparin binding sites in
the N-terminal end of the D2 domain of FGFR. Our results clearly show that
the acid box peptide binds to the ligand binding domain of the fibroblast growth
factor receptor.
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S100A13 is a calcium binding chaperone protein, known to be involved in the
non-classical export of signal peptide less proteins such as fibroblast growth
factor (FGF-1) and interleukin-1a across the cell membrane. It has also been
shown that the interaction of S100A13 with Annexin II, which exhibits an in-
ducible flip-flop mechanism across the cell bilayer, helps the multiprotein re-
lease complex to traverse the membrane bilayer. The interaction of S100A13
and annexin II has been characterized using various biophysical techniques
including multidimensional NMR spectroscopy. Results of the Isothermal titra-
tion calorimetry (ITC) experiments show that holo-S100A13 exhibits preferen-
tial binding to annexin II with high affinity in the micro molar rang compared to
apo-S100A13. Equilibrium guanidine hydrochloride denaturation monitored by
steady-state fluorescence and limited trypsin digestion analysis reveals holo-
S100A13 is significantly stabilized upon binding to annexin II peptide
compared to apo-S100A13. ANS (8-anilino-1-napthalene sulfonate) binding
experiments indicates that the presence of annexin II peptide does not increase
the solvent availability of hydrophobic residues in holo-S100A13. Availability
of the solvent-exposed hydrophobic surface(s) in apoS10013 does not facilitate
its interaction with the annexin II peptide, which is unique characteristic of
S100A13. 1H-15N- HSQC NMR experiments reveal that the binding site of an-
nexin II peptide on holo-S100A13 is modestly different from other S100/An-
nexin interactions. S100 proteins typically interact with more than one Annexin
protein. In order to define the specificity of S100A13 for Annexin 2, the inter-
action of S100A13 with other Annexin peptides was characterized and data
